Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cost-effectiveness of using human papillomavirus 16/18 genotype triage in cervical cancer screening.

Gynecologic oncology - 1 Nov 2010

Vijayaraghavan Arthi, Efrusy Molly B, Goodman Karyn A, Santas Christopher C, Huh Warner K

Abstract excerpt

OBJECTIVE: Testing for human papillomavirus (HPV) 16 and 18 genotypes, which are known to cause approximately 65-70% of invasive cervical cancer cases, may allow clinicians to identify women at highest risk for underlying cervical intraepithelial neoplasia missed by Pap cytology. Our objective was to determine the cost-effectiveness of adding HPV-16 and 18 genotype triage to current cervical cancer screening...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Human papillomavirus 16

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Human papillomavirus 18

Share to Markov Chains

Share to Mass Screening

Share to Monte Carlo Method

Share to Triage

Share to Uterine Cervical Dysplasia

Source

Open in PubMed Open full text

Identifiers

PMID: 20713299
DOI: 10.1016/j.ygyno.2010.07.004
PMCID: PMC4568837

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cost-effectiveness of using human papillomavirus 16/18 genotype triage in cervical cancer screening.PMID 20713299Read ↗

Cost-effectiveness analysis of human papillomavirus (HPV) genotyping strategies for management of HPV-positive women in cervical cancer screening.Semantic proximity Read ↗

The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis.Semantic proximity Read ↗

Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.Semantic proximity Read ↗

Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population-based cervical cancer screening studies from China.Semantic proximity Read ↗

Genotyping and Cytology Triage of High-Risk HPV DNA Positive Women for Detection of Cervical High-Grade Lesions.Semantic proximity Read ↗

Health care policy trial of primary human papillomavirus-based cervical screening in Denmark: Comparison of three triage algorithms.Semantic proximity Read ↗

Lower cost strategies for triage of human papillomavirus DNA‐positive womenSemantic proximity Read ↗

Long-Term Prospective Cohort Study of Cervical Cancer Screening Using Triage of Women Who Are Human Papillomavirus-Positive With Dual Stain and Human Papillomavirus Genotyping.Semantic proximity Read ↗

Triage of HPV positive women in cervical cancer screening.Semantic proximity Read ↗

Benefits, harms and cost-effectiveness of cervical screening and treatment in 78 low-income and lower-middle income countries for women in the general population: modelling to support updated WHO cervical screening and treatment guidelines to prevent cervical cancerSemantic proximity Read ↗

Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening.Semantic proximity Read ↗

Risk-Stratified versus Cytology-Based Triage of Non-HPV 16/18-Positive for Detection of High-Grade Cervical Intraepithelial Neoplasia: Protocol of a Non- Inferiority Randomized Controlled TrialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.